INSIGHTS ON DRUG DEVELOPMENT
-
![GettyImages-2173433148 pfas]( "Take Action On PFAS To Protect Your Critical Processes")
Take Action On PFAS To Protect Your Critical ProcessesPFAS restrictions are tightening, but a full ban could disrupt critical industries lacking alternatives, such as pharmaceutical manufacturing. Learn where PFAS use remains indispensable.
-
![biotech-clinical-trials-GettyImages-917715280]( "Coordinated Development As An Execution Framework")
Coordinated Development As An Execution FrameworkSee how integrating clinical, development, manufacturing, and supply functions within a single execution framework can transform program performance and accelerate development success.
-
![Emulate Liver Chip]( "A Human-Relevant Model Of The Liver Sinusoid")
A Human-Relevant Model Of The Liver SinusoidThis organ-on-a-chip model minimizes drug absorption while maintaining the essential architecture. Explore the specifications of this product engineered to model the human liver.
-
![GettyImages-528971880 chromatography]( "Improving Consumer Safety Through Innovative Science")
Improving Consumer Safety Through Innovative ScienceLiquid chromatography revolutionizes science with precision. Discover a technology that leads the charge in enhancing HPLC performance for breakthroughs in health, safety, and environmental research.
-
Data-Driven Strategies To De-Risk OSD Development6/17/2026
Watch as Quentin Horgan, Director of Drugs Intelligence at GlobalData discusses how early-stage insights can improve development outcomes and reduce downstream risk.
-
Matrix Approach Enhances Potency Assay Development For ATMPs12/22/2025
Potency assays for ATMPs demand precision. Learn how a matrix approach, regulatory alignment, and advanced technologies can overcome variability and ensure safety throughout the product lifecycle.
-
Streamlining Early Drug Development: Efficient Synthesis Of Highly Potent Compounds5/6/2026
Discover how risk‑based, phase‑appropriate synthesis enables safe, efficient production of highly potent compounds while balancing speed, worker safety, and regulatory readiness in early development.
-
The Simplest, Most Powerful Digital PCR Workflow Family3/26/2026
Scalable digital PCR provides high-throughput automation for up to 384 samples. Support seven-color multiplexing and 3D data analysis to achieve superior sensitivity and streamlined laboratory workflows.
-
Creative Chromatography Solutions For Complex Small Molecules6/18/2026
Chromatographic modeling enables smarter purification. Discover how digital tools, fraction mapping, and expert execution can improve yield for the most challenging small-molecule separations.
DRUG DEVELOPMENT SOLUTIONS
-
![drug-product-GettyImages-1293772880]( "Drug Metabolism And Pharmacokinetics (DMPK)")
Curia’s DMPK scientists deliver expert solutions for your drug discovery programs. Providing bioanalytical methods development, in vitro ADMET testing and in vivo PK and PD services that span all stages of drug discovery up to candidate selection.
-
![ValitaTiter Assays for IgG Quantification]( "Rapid, High-Throughput Assays For IgG Quantification")
Rapid, high-throughput IgG quantification assay. Available in 96 & 384-well microplate options.
-
![BD-vystra]( "Disposable Pen For The Self-Injection Of Chronic Disease Medications")
This device is designed for use with a wide range of drug therapies that require variable dosing.
-
![iStock-840784026-protein]( "Potent, Selective Modulators Of Protein Functions")
Explore chemical probes that are selective small-molecule modulators of a protein’s function.
-
![Powder Rheology Feature]( "Powder Rheology Accessory")
The Powder Rheology Accessory expands the DHR’s capabilities to powders, enabling the characterization of behaviors during storage, dispensing, processing, and end-use.
